Oncology Information System Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services (Software, Professional Service), By Application (Radiation Oncology, Medical Oncology, Surgical Oncology), By End User (Hospital & Oncology Clinic, Research Center, Others), By Region, and By Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 9.86 Billion
CAGR (2026-2031)	7.78%
Fastest Growing Segment	Professional Service
Largest Market	North America
Market Size (2031)	USD 15.46 Billion

Market Overview

The Global Oncology Information System Market will grow from USD 9.86 Billion in 2025 to USD 15.46 Billion by 2031 at a 7.78% CAGR. Oncology Information Systems are specialized software solutions designed to manage the comprehensive clinical, administrative, and financial data associated with cancer care to facilitate streamlined workflows across radiation and medical oncology. The primary drivers of this market include the critical necessity to centralize fragmented patient information and the increasing integration of electronic medical records to support precise treatment planning. These platforms are essential for optimizing clinical efficiency and ensuring adherence to evidence-based protocols amidst a rising disease burden.

However, the substantial cost of implementation presents a significant barrier to expansion, particularly for smaller healthcare facilities that struggle with the high capital investment required. Additionally, interoperability issues between disparate digital platforms can often complicate the essential exchange of medical records. The urgency for such robust management tools is underscored by the increasing incidence of the disease. According to the American Cancer Society, in 2025, an estimated 2,041,910 new cancer cases are projected to occur in the United States, highlighting the critical volume of patient data that providers must effectively manage.

Key Market Drivers

The Integration of Artificial Intelligence and Machine Learning in Treatment Planning is acting as a transformative force in the Global Oncology Information System Market, fundamentally reshaping clinical workflows and decision-making processes. These advanced algorithmic tools are increasingly being embedded into oncology information systems to automate complex tasks such as organ segmentation and dose optimization, thereby enhancing precision and reducing the administrative burden on medical staff. As healthcare providers strive to manage the growing complexity of cancer care, the adoption of these intelligent support systems is accelerating. Highlighting this trend, according to OncLive, January 2025, in the 'Survey Says: AI Isn't Going Anywhere in Oncology, But Validity Concerns Remain' article, 26.7% of surveyed oncologists now actively utilize AI tools for treatment decision support systems, indicating a substantial shift toward automated clinical assistance.

Concurrently, Increasing Government Initiatives and Funding for Cancer Research are providing the essential financial framework to support the deployment of these sophisticated digital ecosystems. Public sector investment is critical for modernizing healthcare infrastructure, allowing facilities to procure integrated platforms that centralize patient data and support value-based care models. This commitment is evident in recent policy developments; according to GOV.UK, May 2025, in the 'Government's tech reform to transform cancer diagnosis' press release, the UK government confirmed a £1 billion investment explicitly for digital transformation projects to upgrade NHS diagnostic and data capabilities. Such funding not only facilitates system adoption but also stimulates market activity, a sentiment reflected in the private sector where, according to Siemens Healthineers, November 2024, in the 'Q4 Fiscal Year 2024 Financial Results', the company projected comparable revenue growth of 5% to 6% for fiscal year 2025, driven largely by the sustained demand for advanced oncology solutions.

Download Free Sample Report

Key Market Challenges

The substantial cost of implementation acts as a primary obstruction to the growth of the Global Oncology Information System Market. Comprehensive oncology platforms require significant capital investment for software acquisition, hardware integration, and specialized staff training, creating a high barrier to entry. This financial demand is particularly prohibitive for smaller healthcare facilities and independent practices that lack the vast resources of large academic centers. As a result, these smaller entities often defer the adoption of essential digital management tools, directly reducing the overall market demand and slowing the pace of technological integration across the sector.

Financial constraints are intensified by the disparity between rising operational costs and stagnant reimbursement levels. According to the American Hospital Association, in 2025, general inflation rose by 14.1 percent from 2022 to 2024, while Medicare inpatient payment rates increased by only 5.1 percent. This economic imbalance severely restricts the discretionary budget available to healthcare providers. With margins compressing, organizations must prioritize immediate patient care expenses over new IT investments, thereby hampering the broader expansion of the oncology information system market.

Key Market Trends

The Widespread Adoption of Cloud-Based and SaaS OIS Platforms is modernizing cancer care by replacing rigid on-premise servers with flexible, internet-enabled architectures. These solutions allow multidisciplinary teams to access critical patient data and treatment plans securely from any location, facilitating the remote collaboration essential for complex tumor boards while significantly reducing local hardware maintenance costs. This shift toward agile software environments is directly driving market activity; according to RaySearch Laboratories, November 2025, in the 'Interim report third quarter 2025', the company reported a net sales increase of 13% to SEK 332 million, fueled largely by the robust demand for its RayCare oncology information system and planning software.

The Incorporation of Genomic Data for Precision Oncology Workflows is compelling OIS providers to upgrade systems to handle complex molecular profiles alongside traditional clinical records. As therapies become increasingly targeted based on genetic mutations, oncology platforms must now ingest, store, and visualize next-generation sequencing results to directly support therapeutic decision-making. This integration ensures that clinicians can seamlessly match patients with specific biomarkers to appropriate immunotherapies without leaving their primary workflow. Highlighting the scale of this data utilization, according to Guardant Health, December 2025, in the 'Guardant Health Announces Collaboration with Trial Library' press release, the company leverages a comprehensive real-world data platform of more than 1 million patients tested to optimize the identification of eligible candidates for precision medicine studies.

Segmental Insights

The Professional Service segment represents the fastest-growing category in the Global Oncology Information System Market due to the rising demand for specialized technical support and software implementation. As healthcare facilities adopt comprehensive oncology platforms, they require expert guidance to ensure seamless integration with electronic health records and adherence to protocols established by organizations like the US Food and Drug Administration. This reliance on external expertise for system optimization, staff training, and ongoing maintenance drives the expansion of professional services, allowing medical providers to focus on patient care while ensuring operational efficiency and regulatory compliance.

Regional Insights

North America maintains a dominant position in the global oncology information system market, driven by the extensive adoption of electronic health records and supportive reimbursement frameworks. The region benefits from a well-established healthcare infrastructure that facilitates the integration of patient data. Additionally, organizations such as the National Cancer Institute actively promote the advancement of cancer research and data management, further stimulating market activity. The presence of major software vendors and consistent investment in healthcare information technology also contribute to the high demand for centralized oncology workflow solutions across the region.

Recent Developments

• In September 2025, GE HealthCare announced comprehensive updates to its Intelligent Radiation Therapy (iRT) platform, a software solution dedicated to managing radiation oncology workflows. These enhancements were designed to significantly reduce the time required to transition patients from diagnosis to treatment by leveraging artificial intelligence and improved connectivity with third-party applications. The updated system featured capabilities to better manage complex workflows for theranostics, extending the platform's utility beyond traditional radiation therapy. By automating manual steps and integrating data across disparate oncology systems, the solution aimed to increase departmental efficiency and minimize the risk of errors in treatment planning and delivery.
• In June 2025, RaySearch Laboratories released RayCare v2025, the latest version of its next-generation oncology information system. This update introduced enhanced interoperability features, including seamless integration with Microsoft Word to facilitate consistent clinical documentation directly within patient charts. The system also incorporated DICOM Modality Worklist integration, allowing for the automatic retrieval of patient and appointment data by imaging devices to minimize manual input errors. Additionally, the release included support for HL7 inbound scheduling, enabling the software to receive appointment information from external hospital information systems, thereby improving care coordination and workflow efficiency for oncology departments.
• In April 2025, Elekta entered into a strategic partnership with Azra AI to advance cancer registry operations through artificial intelligence-driven automation. This collaboration integrated Elekta ONE Registry Informatics, a secure cloud-based solution, with Azra AI’s oncology workflow tools to streamline data management and ensure compliance with international standards. The joint solution was designed to automate labor-intensive tasks such as case finding and data entry, significantly reducing the administrative burden on oncology teams. By facilitating real-time patient identification and improving data accuracy, the partnership aimed to optimize hospital operations and support more effective cancer data reporting and analysis.
• In September 2024, Varian, a Siemens Healthineers company, announced a significant ten-year collaboration with Ballad Health to enhance oncology treatment services across rural communities in the Appalachian Highlands. This agreement involved the deployment of the ARIA CORE oncology management solution to replace disparate legacy systems, thereby creating a unified and holistic view of patient information. The partnership aimed to streamline clinical workflows and improve data insights through the Varian Executive Partnership program. By integrating digital solutions across the health system, the initiative sought to accelerate the patient journey from screening through to survivorship and ensure consistent, high-quality care access for regional patients.

Key Market Players

• Elekta AB
• Varian Medical Systems, Inc.
• Epic Systems Corporation
• Philips Healthcare
• Cerner Corporation
• IBM Corporation
• Siemens Healthineers
• RaySearch Laboratories AB
• Koninklijke Philips N.V.
• McKesson Corporation

By Product & Services	By Application	By End User	By Region
Software Professional Service	Radiation Oncology Medical Oncology Surgical Oncology	Hospital & Oncology Clinic Research Center Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Oncology Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Oncology Information System Market, By Product & Services:

• Software
• Professional Service

• Oncology Information System Market, By Application:

• Radiation Oncology
• Medical Oncology
• Surgical Oncology

• Oncology Information System Market, By End User:

• Hospital & Oncology Clinic
• Research Center
• Others

• Oncology Information System Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE